KEGG: cvi:CV_0574
STRING: 243365.CV_0574
What is the genomic context and fundamental characteristics of Proline--tRNA ligase in Chromobacterium violaceum?
Proline--tRNA ligase (ProS) in Chromobacterium violaceum ATCC 12472 is encoded within the complete genome that was sequenced by The Brazilian National Genome Project Consortium . This enzyme belongs to the class II aminoacyl-tRNA synthetase family and catalyzes the attachment of proline to its cognate tRNA in a two-step reaction:
Step 1: Proline + ATP → Prolyl-AMP + PPi
Step 2: Prolyl-AMP + tRNAPro → Prolyl-tRNAPro + AMP
The enzyme exists as a typical class II aminoacyl-tRNA synthetase with characteristic domains for ATP binding, proline recognition, and tRNA interaction. As a critical component of the protein synthesis machinery, ProS ensures translational fidelity by specifically charging tRNA molecules with proline. The gene is located within the context of other protein synthesis genes in the C. violaceum genome, which has been thoroughly characterized through genomic analysis .
What expression systems are most effective for producing recombinant C. violaceum Proline--tRNA ligase?
The optimization of expression systems for recombinant C. violaceum ProS requires careful consideration of several factors:
| Expression System | Advantages | Considerations | Typical Yield (mg/L) |
|---|---|---|---|
| E. coli BL21(DE3) | High yield, simple IPTG induction | May require codon optimization | 10-15 |
| E. coli Rosetta | Accommodates rare codons in C. violaceum | Higher background expression | 8-12 |
| E. coli Arctic Express | Better folding at lower temperatures | Slower growth rates | 5-8 |
| Bacillus subtilis | Suitable for secreted expression | More complex transformation | 3-6 |
Methodological approach for optimal expression:
Clone the proS gene from C. violaceum ATCC 12472 genomic DNA using high-fidelity PCR
Design primers with appropriate restriction sites for directional cloning
Insert into an expression vector (pET28a or similar) with an N-terminal His6-tag
Transform into E. coli BL21(DE3)
Culture at 37°C until OD600 reaches 0.6-0.8
Induce with 0.5 mM IPTG
Shift temperature to 18°C for 16-18 hours to maximize soluble protein production
This approach leverages established expression systems while addressing the specific characteristics of C. violaceum proteins, which may have different folding requirements compared to E. coli proteins.
What purification strategies yield high-purity recombinant C. violaceum Proline--tRNA ligase for structural and functional studies?
A multi-step purification approach is necessary to obtain high-purity C. violaceum ProS suitable for structural and functional characterization:
| Purification Step | Method | Expected Purity | Recovery (%) |
|---|---|---|---|
| Initial Capture | Ni-NTA affinity chromatography | 70-80% | 80-90 |
| Intermediate Purification | Ion exchange chromatography | 85-90% | 70-80 |
| Polishing | Size exclusion chromatography | >95% | 80-90 |
| Optional Step | Heparin affinity chromatography | >98% | 70-80 |
Detailed methodological protocol:
Lyse cells in buffer containing 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM imidazole, 5% glycerol, 1 mM DTT, and protease inhibitors
Apply clarified lysate to Ni-NTA column pre-equilibrated with lysis buffer
Wash with increasing imidazole concentrations (20 mM, 40 mM) to remove non-specifically bound proteins
Elute with 250-300 mM imidazole
If tag removal is desired, incubate with TEV protease (1:50 ratio) during overnight dialysis to reduce salt concentration
Apply to ion exchange column (Q-Sepharose) and elute with salt gradient
Concentrate and apply to Superdex 200 size exclusion column
For nucleic acid-binding studies, include a heparin affinity step to remove any bound nucleic acids
This purification scheme typically yields protein with >95% purity as assessed by SDS-PAGE, suitable for crystallography, enzyme kinetics, and structural biology applications.
What methods are recommended for assessing the aminoacylation activity of purified recombinant C. violaceum Proline--tRNA ligase?
Several complementary methods can be employed to evaluate the aminoacylation activity of purified C. violaceum ProS:
| Method | Principle | Advantages | Limitations |
|---|---|---|---|
| Radioactive Assay | Incorporation of [³H]-proline into tRNA | Gold standard, highly sensitive | Requires radioactive materials |
| Pyrophosphate Release | Measures PPi released in first reaction step | Real-time monitoring, no radioactivity | Only measures first reaction step |
| tRNA Precipitation | Acid precipitation of charged tRNA | Well-established, quantitative | Labor-intensive, requires radioactivity |
| HPLC Analysis | Separation of charged vs. uncharged tRNA | No radioactivity, quantitative | Requires specialized equipment |
| Fluorescence Assay | Using fluorescent ATP analogs | Real-time, no radioactivity | Potential interference with enzyme kinetics |
Standard aminoacylation assay protocol:
Prepare reaction mixture containing 100 mM HEPES-KOH pH 7.5, 10 mM MgCl₂, 50 mM KCl, 5 mM DTT, 4 mM ATP, 50 μM [³H]-proline, 10 μM tRNAPro, and purified enzyme (10-100 nM)
Incubate at 37°C and remove aliquots at different time points (0-10 minutes)
Spot aliquots on Whatman filter paper pre-soaked with 5% trichloroacetic acid
Wash filters extensively with 5% TCA to remove unincorporated [³H]-proline
Quantify incorporated radioactivity by liquid scintillation counting
Calculate initial velocities and specific activity (nmol/min/mg protein)
These methods provide complementary approaches to characterize the enzymatic activity of C. violaceum ProS, enabling researchers to select the most appropriate technique based on available equipment and specific research questions.
How does C. violaceum Proline--tRNA ligase compare with homologous enzymes from other bacterial species?
Comparative analysis of C. violaceum ProS with homologs from other bacterial species reveals important evolutionary and functional insights:
| Characteristic | C. violaceum ProS | E. coli ProS | P. aeruginosa ProS |
|---|---|---|---|
| Protein Length | ~570 amino acids* | 572 amino acids | 584 amino acids |
| Domain Structure | Catalytic, anticodon-binding | Catalytic, anticodon-binding | Catalytic, anticodon-binding |
| Editing Domain | Present* | Present | Present |
| Dimerization | Likely homodimer* | Homodimer | Homodimer |
| Zinc Binding | Likely present* | Present | Present |
| Taxonomic Context | β-proteobacteria | γ-proteobacteria | γ-proteobacteria |
*Based on comparative analysis with related species, as C. violaceum is a member of the Neisseriaceae family of Betaproteobacteria
Methodological approaches for comprehensive comparison:
Multiple sequence alignment using MUSCLE or CLUSTALW algorithms
Phylogenetic analysis using maximum likelihood methods
Homology modeling based on available crystal structures
Structural superposition to identify conserved catalytic residues
Comparative biochemical analysis of substrate specificities and kinetic parameters
Analysis of species-specific insertions or deletions that may affect function
C. violaceum ProS likely shares core catalytic mechanisms with other bacterial ProRS enzymes while possessing unique features related to its adaptation to the organism's environmental niche in tropical and subtropical regions . Understanding these differences can provide insights into evolutionary adaptation of aminoacyl-tRNA synthetases across bacterial species.
What role might C. violaceum Proline--tRNA ligase play in bacterial pathogenesis and virulence?
While direct evidence for ProS involvement in C. violaceum pathogenesis is limited, several compelling connections can be explored:
C. violaceum is an opportunistic pathogen capable of causing fatal infections in humans and animals, with cases of septicemia reported in medical literature . The organism possesses several virulence factors, most notably two Type III Secretion Systems (T3SSs) encoded by Chromobacterium pathogenicity islands Cpi-1/1a and Cpi-2 .
Potential roles of ProS in pathogenesis include:
Regulation of Virulence Factor Translation:
ProS activity may modulate translation efficiency of virulence factors during infection
The T3SS components require precise temporal expression, potentially regulated at the translational level
Stress Adaptation During Infection:
ProS may function differently under host-associated stress conditions
Altered aminoacylation efficiency could enable rapid adaptation to the host environment
Potential Moonlighting Functions:
Similar to other aminoacyl-tRNA synthetases, ProS may have non-canonical functions
These could include signaling roles or direct interactions with host components
Experimental approaches to investigate these hypotheses:
Generate conditional ProS mutants and evaluate virulence in mouse infection models
Examine protein synthesis patterns during infection using ribosome profiling
Assess ProS expression during different stages of infection
Test for direct interactions between ProS and components of the T3SS machinery
The Cpi-1/1a T3SS has been demonstrated as a major virulence determinant for C. violaceum , and understanding ProS's potential regulatory role could provide new insights into pathogenesis mechanisms.
How can structural studies of C. violaceum Proline--tRNA ligase inform drug development against bacterial infections?
Structural studies of C. violaceum ProS can provide valuable insights for antimicrobial development:
| Structural Element | Potential Therapeutic Relevance | Methodological Approaches |
|---|---|---|
| Active Site | High-affinity inhibitor design | X-ray crystallography with substrate analogs |
| Species-Specific Pockets | Selectivity for bacterial over human enzyme | Structural comparison with human ProRS |
| Conformational Dynamics | Allosteric inhibitor development | HDX-MS, NMR relaxation studies |
| tRNA Recognition Elements | Disruption of tRNA binding | Cryo-EM of ProS-tRNA complexes |
| Dimerization Interface | Destabilization of functional quaternary structure | Interface analysis, mutagenesis |
Experimental strategy for structure-based drug discovery:
Solve high-resolution crystal structures of C. violaceum ProS in multiple states:
Apo-enzyme
Enzyme-ATP complex
Enzyme-proline complex
Enzyme-prolyl-AMP complex
Enzyme-tRNA complex
Identify druggable pockets through computational analysis:
Molecular dynamics simulations to identify transient pockets
Fragment-based screening against crystallographic structures
Virtual screening of compound libraries
Develop and validate binding assays:
Thermal shift assays to detect stabilizing compounds
Surface plasmon resonance for binding kinetics
Isothermal titration calorimetry for thermodynamic parameters
Establish structure-activity relationships:
Medicinal chemistry optimization of hit compounds
Co-crystallization with promising inhibitors
Activity assays against C. violaceum and other pathogenic bacteria
Such approaches could potentially lead to new antimicrobial compounds effective against C. violaceum infections, which are often fatal and resistant to many conventional antibiotics . Additionally, targeting aminoacyl-tRNA synthetases represents an established antimicrobial strategy with precedents in clinical use.
What experimental approaches can determine whether C. violaceum Proline--tRNA ligase possesses editing activity against misacylated tRNAs?
Determining the editing activity of C. violaceum ProS requires specialized methodological approaches:
| Approach | Principle | Technical Implementation | Expected Outcomes |
|---|---|---|---|
| Pre-transfer Editing | Hydrolysis of non-cognate aminoacyl-AMPs | Thin-layer chromatography with radiolabeled amino acids | Quantification of AMP release from mischarged intermediates |
| Post-transfer Editing | Deacylation of mischarged tRNAs | Acid gel electrophoresis of tRNA species | Visualization of charged vs. uncharged tRNA populations |
| Misactivation Assays | Activation of near-cognate amino acids | ATP-PPi exchange assays with various amino acids | Determination of discrimination factors |
| Genetic Complementation | Rescue of editing-deficient strains | Expression in editing-deficient E. coli | Assessment of growth under stress conditions |
| Mutagenesis Studies | Creation of editing-deficient variants | Site-directed mutagenesis of predicted editing residues | Comparison of wild-type vs. mutant editing activities |
Detailed post-transfer editing assay protocol:
Prepare mischarged [³H]-Ala-tRNAPro using an editing-deficient ProRS variant
Purify the mischarged tRNA by phenol extraction and ethanol precipitation
Incubate purified mischarged tRNA (1 μM) with wild-type C. violaceum ProS (100 nM)
At various time points (0-30 minutes), take aliquots and precipitate tRNA with TCA
Measure the decrease in acid-precipitable radioactivity over time
Calculate deacylation rate constants (kdeacyl) for the editing reaction
Compare with deacylation rates for correctly charged Prolyl-tRNAPro (control)
Editing activity is critical for preventing mistranslation of proline codons with alanine or cysteine, which could be particularly important during C. violaceum infection processes. Given C. violaceum's environmental versatility and pathogenic potential , its ProS may have evolved specific editing mechanisms to maintain translational fidelity under diverse conditions.
How might post-translational modifications regulate C. violaceum Proline--tRNA ligase activity during environmental adaptation?
Post-translational modifications (PTMs) of C. violaceum ProS could serve as regulatory mechanisms during environmental adaptation:
| Modification Type | Potential Regulatory Function | Detection Method | Biological Context |
|---|---|---|---|
| Phosphorylation | Rapid activity modulation during stress | Phosphoproteomics, Phos-tag gels | Stress response signaling |
| Acetylation | Metabolic adaptation, carbon source shifts | Western blot with anti-acetyl lysine | Metabolic regulation |
| Oxidative Modifications | Redox sensing during host defense | Mass spectrometry with differential labeling | Oxidative stress response |
| Proteolytic Processing | Long-term activity regulation | N-terminal sequencing, size shift detection | Adaptation to chronic stress |
| Pupylation/Ubiquitination | Targeted degradation | Immunoprecipitation with specific antibodies | Protein turnover regulation |
Comprehensive experimental approach:
C. violaceum's ability to adapt to diverse environments, from soil and water to human hosts , suggests sophisticated regulatory mechanisms may control its core physiological processes. Understanding how ProS activity is modulated through PTMs could reveal critical adaptation mechanisms relevant to both environmental persistence and pathogenicity.
What role might C. violaceum Proline--tRNA ligase play in bacterial stress responses, and how can this be experimentally validated?
Investigating the potential role of C. violaceum ProS in stress responses requires targeted experimental approaches:
Comprehensive experimental design:
Generate conditional ProS mutants in C. violaceum:
Construct strains with ProS under inducible promoter control
Create point mutations in key functional domains
Develop depletion systems to reduce ProS levels
Expose these strains to various stresses and assess:
Growth kinetics under stress conditions
Global translation rates using puromycin incorporation
Specific stress response protein synthesis
Mistranslation frequency using reporter systems
Virulence factor expression and secretion
Monitor ProS expression and modifications:
Quantitative RT-PCR for transcriptional regulation
Western blotting for protein levels and modifications
Fluorescent tagging for subcellular localization during stress
Assess impact on pathogenicity:
Mouse infection models comparing wild-type and ProS variant strains
Ex vivo macrophage infection assays
T3SS functionality tests with ProS depletion
C. violaceum's remarkable adaptability to diverse environmental conditions and its capacity to switch from a free-living to pathogenic lifestyle suggest sophisticated stress response mechanisms. ProS may function as both an essential housekeeping enzyme and a regulatory component in stress adaptation networks, particularly in coordinating protein synthesis with environmental challenges.